Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Increased Matrix Metalloproteinase (MMPs) Levels Do Not Predict Disease Severity or Progression in Emphysema

D'Armiento, JM and Goldklang, MP and Hardigan, AA and Geraghty, P and Roth, MD and Connett, JE and Wise, RA and Sciurba, FC and Scharf, SM and Thankachen, J and Islam, M and Ghio, AJ and Foronjy, RF (2013) Increased Matrix Metalloproteinase (MMPs) Levels Do Not Predict Disease Severity or Progression in Emphysema. PLoS ONE, 8 (2).

Published Version
Available under License : See the attached license file.

Download (906kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Rationale: Though matrix metalloproteinases (MMPs) are critical in the pathogenesis of COPD, their utility as a disease biomarker remains uncertain. This study aimed to determine whether bronchoalveolar lavage (BALF) or plasma MMP measurements correlated with disease severity or functional decline in emphysema. Methods: Enzyme-linked immunosorbent assay and luminex assays measured MMP-1, -9, -12 and tissue inhibitor of matrix metalloproteinase-1 in the BALF and plasma of non-smokers, smokers with normal lung function and moderate-to-severe emphysema subjects. In the cohort of 101 emphysema subjects correlative analyses were done to determine if MMP or TIMP-1 levels were associated with key disease parameters or change in lung function over an 18-month time period. Main Results: Compared to non-smoking controls, MMP and TIMP-1 BALF levels were significantly elevated in the emphysema cohort. Though MMP-1 was elevated in both the normal smoker and emphysema groups, collagenase activity was only increased in the emphysema subjects. In contrast to BALF, plasma MMP-9 and TIMP-1 levels were actually decreased in the emphysema cohort compared to the control groups. Both in the BALF and plasma, MMP and TIMP-1 measurements in the emphysema subjects did not correlate with important disease parameters and were not predictive of subsequent functional decline. Conclusions: MMPs are altered in the BALF and plasma of emphysema; however, the changes in MMPs correlate poorly with parameters of disease intensity or progression. Though MMPs are pivotal in the pathogenesis of COPD, these findings suggest that measuring MMPs will have limited utility as a prognostic marker in this disease. © 2013 D'Armiento et al.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
D'Armiento, JM
Goldklang, MP
Hardigan, AA
Geraghty, P
Roth, MD
Connett, JE
Wise, RA
Sciurba, FCfcs@pitt.eduFCS
Scharf, SM
Thankachen, J
Islam, M
Ghio, AJ
Foronjy, RF
Date: 18 February 2013
Date Type: Publication
Journal or Publication Title: PLoS ONE
Volume: 8
Number: 2
DOI or Unique Handle: 10.1371/journal.pone.0056352
Schools and Programs: School of Medicine > Medicine
Refereed: Yes
Other ID: NLM PMC3575373
PubMed Central ID: PMC3575373
PubMed ID: 23441181
Date Deposited: 28 Mar 2013 16:44
Last Modified: 02 Feb 2019 18:55


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item